First-in-Class Epigenetic Silencer TUNE-401 Shows Positive Phase 1b/2a Proof-of-Concept Data for Hepatitis B at EASL 2026
Initial clinical data demonstrates deep and durable antiviral activity, including direct silencing of cccDNA, offering a potential pathway to a finite cure for HBV patients — with significant implications for China, home to the world’s…
China’s Advanced Peptide Manufacturers: Supplying Global Research and Wellness Markets with Precision Synthesis
The global landscape for specialized pharmaceuticals is undergoing a significant shift, and Chinese manufacturers are at the epicenter of supplying critical compounds. Amidst a growing international d
Leading China-Based Peptide Manufacturer for FDA-Approved and Custom API Production
In the dynamic and highly regulated world of pharmaceutical active ingredients, a select group of Chinese suppliers has risen to become indispensable partners for global health companies. **Jiangsu Pe
China’s Palantir: How Xunce Technology’s Doubled Stock Signals a New Era in AI Data Analytics and Hong Kong Market Gr…
The global technology investment landscape is constantly seeking the next paradigm-shifting company, and the recent explosive debut of a Chinese data analytics firm has sent a clear signal to the mark
Premium Chinese Peptide Manufacturing Partner for Next-Generation Biotech: Strategic CMO for Regulated Markets
The global biopharmaceutical landscape is undergoing a seismic shift, particularly in the peptide therapeutics sector, driven by new regulatory pathways and evolving treatment paradigms. At the heart
Reliable Chinese Peptide Manufacturers Driving Global Metabolic Health Innovation
The global pharmaceutical landscape is undergoing a significant transformation, driven by breakthroughs in metabolic health and peptide therapeutics. At the heart of this revolution is a robust and ra
Hong Kong IPO Market Faces Post-Debut Stock Underperformance Amid Global Leadership
BEIJING — **Hong Kong** may reign supreme as the world's leading market for initial public offerings by funds raised, but a troubling shadow looms over its glittering record. The city's exchange, whil
How Made in China 2025 Is Reshaping OEM Manufacturing and Trademark Law for Global Brands
For decades, the world's supply chains were built on a simple, powerful equation: Western brands designed, Chinese factories manufactured. This symbiotic relationship, epitomized by **OEM (Original Eq
How China’s Biotech Revolution Is Redefining Global Pharma Innovation and Patent Cliff Solutions
For decades, the narrative surrounding China's pharmaceutical industry was clear and singular: it was the world's factory for cost-efficient generics. This reputation, however, is undergoing a seismic
China’s Biotech Boom: How Innovative Chinese Pharma Companies are Redefining Global Drug Development and Commercializ…
The narrative of global pharmaceutical innovation is being rewritten, with a dynamic new chapter emerging from China. No longer just a hub for generic manufacturing or clinical trial services, the cou
